143 related articles for article (PubMed ID: 36042366)
1. Levels of soluble tumor necrosis factor receptor 1 and 2 are associated with survival after ST segment elevation myocardial infarction.
Befekadu R; Grenegård M; Larsson A; Christensen K; Ramström S
Sci Rep; 2022 Aug; 12(1):14762. PubMed ID: 36042366
[TBL] [Abstract][Full Text] [Related]
2. Serum Soluble Tumor Necrosis Factor Receptors 1 and 2 Are Early Prognosis Markers After ST-Segment Elevation Myocardial Infarction.
Paccalet A; Crola Da Silva C; Mechtouff L; Amaz C; Varillon Y; de Bourguignon C; Cartier R; Prieur C; Tomasevic D; Genot N; Leboube S; Derimay F; Rioufol G; Bonnefoy-Cudraz E; Mewton N; Ovize M; Bidaux G; Bochaton T
Front Pharmacol; 2021; 12():656928. PubMed ID: 34539391
[No Abstract] [Full Text] [Related]
3. Soluble TNF receptors are associated with infarct size and ventricular dysfunction in ST-elevation myocardial infarction.
Nilsson L; Szymanowski A; Swahn E; Jonasson L
PLoS One; 2013; 8(2):e55477. PubMed ID: 23405158
[TBL] [Abstract][Full Text] [Related]
4. TNF-α and soluble forms of TNF receptors 1 and 2 in the serum of patients with Crohn's disease and ulcerative colitis.
Owczarek D; Cibor D; Głowacki MK; Cieśla A; Mach P
Pol Arch Med Wewn; 2012; 122(12):616-23. PubMed ID: 23160117
[TBL] [Abstract][Full Text] [Related]
5. Plasma concentrations of TNF-alpha and its soluble receptors sTNFR1 and sTNFR2 in patients with coronary artery disease.
Safranow K; Dziedziejko V; Rzeuski R; Czyzycka E; Wojtarowicz A; Bińczak-Kuleta A; Jakubowska K; Olszewska M; Ciechanowicz A; Kornacewicz-Jach Z; Machaliński B; Pawlik A; Chlubek D
Tissue Antigens; 2009 Nov; 74(5):386-92. PubMed ID: 19845893
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor alpha (TNF-α) and its soluble receptors are associated with disability, disability progression and clinical forms of multiple sclerosis.
Ribeiro CM; Oliveira SR; Alfieri DF; Flauzino T; Kaimen-Maciel DR; Simão ANC; Maes M; Reiche EMV
Inflamm Res; 2019 Dec; 68(12):1049-1059. PubMed ID: 31559449
[TBL] [Abstract][Full Text] [Related]
7. Levels of TNF-α, soluble TNF receptors (sTNFR1, sTNFR2), and cognition in bipolar disorder.
Doganavsargil-Baysal O; Cinemre B; Aksoy UM; Akbas H; Metin O; Fettahoglu C; Gokmen Z; Davran F
Hum Psychopharmacol; 2013 Mar; 28(2):160-7. PubMed ID: 23532748
[TBL] [Abstract][Full Text] [Related]
8. Significant Induction of Soluble TNFR2 Compared with TNFR1 in Serum Samples of HIV Patients with or without Antiretroviral Medication.
Sarfo B; Haile ZT; Deletsu S; Mensah EA; Bonney EY
Infect Disord Drug Targets; 2020; 20(2):175-181. PubMed ID: 30324895
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-alpha and soluble TNF-alpha receptor responses in young vs. middle-aged males following eccentric exercise.
Arroyo E; Wells AJ; Gordon JA; Varanoske AN; Gepner Y; Coker NA; Church DD; Fukuda DH; Stout JR; Hoffman JR
Exp Gerontol; 2017 Dec; 100():28-35. PubMed ID: 29038027
[TBL] [Abstract][Full Text] [Related]
10. Plasma Soluble Tumor Necrosis Factor Receptor Concentrations and Clinical Events After Hospitalization: Findings From the ASSESS-AKI and ARID Studies.
Coca SG; Vasquez-Rios G; Mansour SG; Moledina DG; Thiessen-Philbrook H; Wurfel MM; Bhatraju P; Himmelfarb J; Siew E; Garg AX; Hsu CY; Liu KD; Kimmel PL; Chinchilli VM; Kaufman JS; Wilson M; Banks RE; Packington R; McCole E; Kurth MJ; Richardson C; Go AS; Selby NM; Parikh CR
Am J Kidney Dis; 2023 Feb; 81(2):190-200. PubMed ID: 36108888
[TBL] [Abstract][Full Text] [Related]
11. Prolonged activation of tumor necrosis factor (TNF)-alpha and its soluble receptors in chronic heart failure patients both in the compensated and decompensated state. Interplay between their levels and metalloproteinase-3.
Tziakas D; Chalikias G; Parissis JT; Hatzinikolaou H; Stakos D; Papadopoulou E; Kortsaris A; Hatseras D
Eur Cytokine Netw; 2004; 15(3):231-9. PubMed ID: 15542448
[TBL] [Abstract][Full Text] [Related]
12. Thrombus Aspiration in ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis: Thrombectomy Trialists Collaboration.
Jolly SS; James S; Džavík V; Cairns JA; Mahmoud KD; Zijlstra F; Yusuf S; Olivecrona GK; Renlund H; Gao P; Lagerqvist B; Alazzoni A; Kedev S; Stankovic G; Meeks B; Frøbert O
Circulation; 2017 Jan; 135(2):143-152. PubMed ID: 27941066
[TBL] [Abstract][Full Text] [Related]
13. Plasma levels of the soluble fraction of tumor necrosis factor receptors 1 and 2 are independent determinants of plasma cholesterol and LDL-cholesterol concentrations in healthy subjects.
Fernández-Real JM; Gutiérrez C; Ricart W; Castiñeira MJ; Vendrell J; Richart C
Atherosclerosis; 1999 Oct; 146(2):321-7. PubMed ID: 10532687
[TBL] [Abstract][Full Text] [Related]
14. Adipokines, tumor necrosis factor and its receptors in female patients with systemic lupus erythematosus.
Santos FM; Telles RW; Lanna CC; Teixeira AL; Miranda AS; Rocha NP; Ribeiro AL
Lupus; 2017 Jan; 26(1):10-16. PubMed ID: 27365371
[TBL] [Abstract][Full Text] [Related]
15. Dynamic Changes in Pentraxin-3 and Neprilysin in ST Segment Elevation Myocardial Infarction.
Befekadu R; Grenegård M; Larsson A; Christensen K; Ramström S
Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203485
[TBL] [Abstract][Full Text] [Related]
16. Soluble tumour necrosis factor receptors sTNFR1 and sTNFR2 are produced at sites of inflammation and are markers of arthritis activity in Behçet's disease.
Turan B; Pfister K; Diener PA; Hell M; Möller B; Boyvat A; Ergin S; Villiger PM
Scand J Rheumatol; 2008; 37(2):135-41. PubMed ID: 18415772
[TBL] [Abstract][Full Text] [Related]
17. Soluble tumor necrosis factor receptor 1 and 2 predict outcomes in advanced chronic kidney disease: a prospective cohort study.
Neirynck N; Glorieux G; Schepers E; Verbeke F; Vanholder R
PLoS One; 2015; 10(3):e0122073. PubMed ID: 25823004
[TBL] [Abstract][Full Text] [Related]
18. Atorvastatin reduced soluble receptors of TNF-alpha in systemic lupus erythematosus.
Ferreira GA; Teixeira AL; Calderaro DC; Sato EI
Clin Exp Rheumatol; 2016; 34(1):42-8. PubMed ID: 26574625
[TBL] [Abstract][Full Text] [Related]
19. Soluble tumor necrosis factor receptors are associated with severity of kidney dysfunction in pediatric chronic kidney disease.
Moreira JM; da Silva AN; Marciano Vieira ÉL; Teixeira AL; Kummer AM; Simões E Silva AC
Pediatr Nephrol; 2019 Feb; 34(2):349-352. PubMed ID: 30374604
[TBL] [Abstract][Full Text] [Related]
20. Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease.
Diniz BS; Teixeira AL; Ojopi EB; Talib LL; Mendonça VA; Gattaz WF; Forlenza OV
J Alzheimers Dis; 2010; 22(4):1305-11. PubMed ID: 20930310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
